KPV (4mg)

KPV represents a C-terminal peptide fragment derived from alpha-melanocyte stimulating hormone (alpha-MSH). It is one among numerous short peptide derivatives of alpha-MSH that has undergone evaluation to determine its retention of photoprotective properties, efficacy against ischemia, sexual impacts, and influence on feeding behavior and energy homeostasis. Comprised of lysine-proline-valine, KPV has revealed considerable anti-inflammatory effects and is currently under active investigation as a potential therapeutic agent for inflammatory bowel disease. Research has demonstrated its robust anti-inflammatory activity within the central nervous system, gastrointestinal tract, lungs, vascular system, and joints. Due to its diminutive size, KPV can be delivered via multiple routes, encompassing oral, intravenous, and transdermal modes of administration.

DISCLAIMER: FOR EXPERIMENTAL USE ONLY, NOT FOR PERSONAL USE